Loading stock data…
THC
$191.68+1.30 (+0.68%)
Market ClosedLast close May 11
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tenet Healthcare Corporation in the Healthcare sector is trading at $191.68. The stock is currently 22% below its 52-week high of $247.21, remaining 3.1% below its 200-day moving average. Technical signals show neutral RSI of 55 and bullish MACD crossover, explaining why THC maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 55) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$191.68
Potential Upside
105.8%
Whystock Fair Value$394.41
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus21 analysts
Mean target$245.52+28.1%
Range$210.00 – $288.00
Fundamentals
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$16.50B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.17
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
35.17%
Volume
Today's trading volume
872,091
Recent News
AUNA Q1 Earnings Preview: How Should You Play the Stock Now?
AUNA S.A. heads into May 19 Q1 results with a flat EPS outlook and 8%+ revenue growth expected, but weak signals from Mexico and mixed regional trends cloud sentiment.
Tenet Healthcare (THC) Is Up 9.6% After Raising 2026 Earnings Guidance And Completing Buybacks – Has The Bull Case Changed?
In late April 2026, Tenet Healthcare reported first-quarter 2026 results showing higher sales of US$5,368 million and increased net income of US$702 million, while also completing a share repurchase program totaling 10.91 million shares for US$1.83 billion under its July 24, 2024 authorization. The company also issued full-year 2026 guidance with projected net operating revenues of US$21.50–US$22.30 billion and diluted EPS of US$29.94–US$32.64, highlighting how margin gains and cost controls...
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View
Tenet Healthcare tops Q1 EPS estimates as admissions and ambulatory growth drive gains, but payer mix pressures and rising costs weigh on margins.
Encompass Health Q1 EPS Tops, Revenues Climb on Solid Discharges
EHC posts Q1 EPS beat as revenues rise 9%, driven by higher patient revenue and volumes, though rising costs and expenses temper gains.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.